PANACEA BIOTEC LTD. - 531349 - USFDA Inspection Of The Company'S Material Wholly-Owned Subsidiary, Panacea Biotec Pharma Limited'S Facility At Baddi, Himachal Pradesh, India
Please find enclosed disclosure under Regulation 30 of the SEBI LODR Regulations regarding closure of the USFDA Inspection of the Company''s material wholly owned subsidiary, Panacea Biotec Pharma Ltd.''s facility at Baddi, Himachal Pradesh, India PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith a certificate dated October 04, 2023, issued by Skyline Financial Services Private Limited, Registrar and Transfer Agent of the Company, confirming compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2023. PANACEA BIOTEC LTD. - 531349 - Details Of Shares Dematerialised During The Month Of September, 2023
Please find enclosed herewith the details of shares dematerialised during the month of September, 2023 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 PANACEA BIOTEC LTD. - 531349 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation regarding commencement of arbitration proceeding with respect to the request for Arbitration filed by Apotex Inc., an entity based out in Canada against the Company for arbitration of dispute between the parties is enclosed herewith PANACEA BIOTEC LTD. - 531349 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Details of the Voting Results pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed herewith PANACEA BIOTEC LTD. - 531349 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
The detailed voting results along with Scrutinizer''s Report for the Annual General Meeting held on September 29, 2023 is enclosed herewith. PANACEA BIOTEC LTD. - 531349 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find enclosed herewith the proceedings of the 39th Annual General Meeting of the Company held on Friday, September 29, 2023 at 11:30 A.M. through video Conferencing. PANACEA BIOTEC LTD. - 531349 - Closure of Trading Window
We would like to inform you that the trading window of the Company shall remain closed for all the Designated Persons of the Company from October 01, 2023 till completion of 48 hours from the announcement to the Stock Exchanges regarding Unaudited financial results of the Company for quarter and half year ended September 30, 2023. The date of meeting of the Board to approve the Unaudited financial results of the Company for the quarter and half year ended September 30, 2023, shall be informed in due course.
Panacea Biotec hits 52-week high on Serum Institute selling off 4 lakh shares
According to the data published by the NSE, the vaccine maker sold its shares in the company for the second time in the ongoing quarter after having offloaded 5 lakh shares in August at an average price of Rs 146.31. PANACEA BIOTEC LTD. - 531349 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Serum Institute of India Pvt Ltd